Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines

Archiv der Pharmazie

Volumn 341, Issue 7, 2008, Pages 435-439

  Trivedi, Amit ^a   Dodiya, Dipti ^a   Surani, Janak ^a   Jarsania, Samir ^a   Mathukiya, Hitesh ^a   Ravat, Naresh ^a   Shah, Viresh ^a  

^a SAURASHTRA UNIVERSITY   (India)

Author keywords

Antimycobacterial activity; Antitubercular activity; Mycobacterium tuberculosis H37Rv; One pot synthesis; Pyrazolo 3,4 d pyrimidines

Indexed keywords

6 AMINO 4 (5 CHLORO 3 METHYL 1 PHENYL 1H PYRAZOL 4 YL) 1 (2 CHLORO 5 SULFOPHENYL) 4,5 DIHYDRO 3 METHYL 1H PYRAZOLO[3,4 D]PYRIMIDINE; 6 AMINO 4 (5 CHLORO 3 METHYL 1 PHENYL 1H PYRAZOL 4 YL) 1 (2 CHLOROPHENYL) 4,5 DIHYDRO 3 METHYL 1H PYRAZOLO[3,4 D]PYRIMIDINE; 6 AMINO 4 (5 CHLORO 3 METHYL 1 PHENYL 1H PYRAZOL 4 YL) 1 (2,5 DICHLORO 4 SULFOPHENYL) 4,5 DIHYDRO 3 METHYL 1H PYRAZOLO[3,4 D]PYRIMIDINE; 6 AMINO 4 (5 CHLORO 3 METHYL 1 PHENYL 1H PYRAZOL 4 YL) 1 (3 CHLOROPHENYL) 4,5 DIHYDRO 3 METHYL 1H PYRAZOLO[3,4 D]PYRIMIDINE; 6 AMINO 4 (5 CHLORO 3 METHYL 1 PHENYL 1H PYRAZOL 4 YL) 1 (3 SULFOPHENYL) 4,5 DIHYDRO 3 METHYL 1H PYRAZOLO[3,4 D]PYRIMIDINE; 6 AMINO 4 (5 CHLORO 3 METHYL 1 PHENYL 1H PYRAZOL 4 YL) 1 (4 METHYLPHENYL) 4,5 DIHYDRO 3 METHYL 1H PYRAZOLO[3, 4 D]PYRIDIMINE; 6 AMINO 4 (5 CHLORO 3 METHYL 1 PHENYL 1H PYRAZOL 4 YL) 1 (4 SULFOPHENYL) 4,5 DIHYDRO 3 METHYL 1H PYRAZOLO[3,4 D]PYRIMIDINE; 6 AMINO 4 (5 CHLORO 3 METHYL 1 PHENYL 1H PYRAZOL 4 YL) 4,5 DIHYDRO 3 METHYL 1 PHENYL 1H PYRAZOLO[3,4 D]PYRIMIDINE; ANTIINFECTIVE AGENT; ISONIAZID; PYRIMIDINE DERIVATIVE; RIFAMPICIN; UNCLASSIFIED DRUG; OXAZINE DERIVATIVE; RESAZURIN; TUBERCULOSTATIC AGENT; XANTHENE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; EVALUATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; COMPARATIVE STUDY; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OXAZINES; PYRIMIDINES; RIFAMPIN; STRUCTURE-ACTIVITY RELATIONSHIP; TUBERCULOSIS, MULTIDRUG-RESISTANT; XANTHENES;

EID: 52449116295     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200800027     Document Type: Article

References (34)

1. R. Filler, Chem. Technol. 1974, 4, 752-757.
2. M. M. Ghorab, Z. H. Ismail, S. M. Abdel-Gawad, A. Abdel Aziem, Heteroatom Chemistry 2004, 15, 57-62.
3. L. P. Davies, D. J. Brown, S. C. Chow, G. A. R. Johnston, Neurosci. Lett. 2004, 41, 189-193.
4. L. P. Davies, S. C. Chow, J. H. Skerritt, D. J. Brown, G. A. R. Johnston, Life Sci. 1984, 34, 2117-212.
5. J. H. Burchenal, M. L. Murphy, R. R. Ellison, M. P. Sykes, et al., Blood 1953, 8, 965-999.
6. G. B. Elion, J. Med. Virol. 1993, 41, 2-6.
7. R. W. Rundles, Arch. Intern. Med. 1985, 145, 1492-1503.
8. G. Chiosis, M. N. Timaul, B. Lucas, P. N. Munster, et al., Chem. Biol. 2001, 8, 289-299.
9. C. M. Crews, R. Mohan, Curr. Opin. Chem. Biol. 2000, 4, 47-53.
10. M. Knockaert, N. Gray, E. Damiens, Y.-T. Chang, et al., Chem. Biol. 2000, 7, 411-422.
11. S. A. Laufer, D. M. Domeyer, T. R. Scior, W. Albrecht, D. R. Hauser, J. Med. Chem. 2005, 48, 710-722.
12. J. I. Armstrong, A. R. Portley, Y.-T. Chang, D. M. Nierengarten, et al., Angew. Chem. Int. Ed. Engl. 2000, 39, 1303-1306.
13. D. E. Verdugo, M. T. Cancilla, X. Ge, N. S. Gray, et al., J. Med. Chem. 2001, 44, 2683-2686.
14. X. Wu, S. Ding, Q. Ding, N. S. Gray, P. G. Schultz, J. Am. Chem. Soc. 2002, 124, 14521-14520.
15. L. L. Gundersen, J. Nissen-Meyer, B. Spilsberg, J. Med. Chem. 2002, 45, 1383-1386.
16. A. Scozzafava, A. Mastrolorenzo, C. T. Supuran, Bioorg. Med. Chem. Lett. 2001, 11, 1675-1678.
17. V. Klimešová, J. Kocí, K. Waisser, J. Kaustová, Farmaco 2002, 57, 259-265.
18. A. K. Pathak, V. Pathak, L. E. Seitz, W. J. Suling, R. C. Reynolds, J. Med. Chem. 2004, 47, 273-276.
19. O. Moukha-Chafiq, M. L. Taha, H. B. Lazrek, J.-L. Barascut, J.-L. Imbach, C. R. Acad. Sci. IIc: Chimie 2000, 3, 639-641.
20. J. H. Hanke, J. P. Gardner, R. L. Dow, P. S. Changelian, et al., J. Biol. Chem. 1996, 271, 695-701.
21. P. Traxler, P. Furet, Pharmacol. Ther. 1999, 82, 195-206.
22. M. R. Bergman, B. J. Holycross, J. Pharmacol. Exp. Ther. 1996, 279, 247-254.
23. A. Ali, G. E. Taylor, K. Ellsworth, G. Harris, et al., J. Med. Chem. 2003, 46, 1824-1830.
24. J. O. Moukha-Chafiq, M. L. Taha, H. B. Lazrek, C. Pannecouque, et al., Nucleosides Nucleotides Nucleic Acids 2001, 20, 1797-1810.
25. O. Moukha-Chafiq, M. L. Taha, H. B. Lazrek, J. J. Vasseur, C. E. De, Nucleosides Nucleotides Nucleic Acids 2002, 21, 165-176.
26. M. L. Taha, O. Moukha-Chafiq, H. B. Lazrek, J. J. Vasseur, J. L. Imbach, Nucleosides Nucleotides Nucleic Acids 2001, 20, 955-958.
27. F. Yoneda, M. Higuchi, T. Nagamatsu, J. Am. Chem. Soc. 1974, 96, 5607-5608.
28. Y. Maki, K. Izuka, M. Suzuki, J. Chem. Soc. Chem. Commun. 1971, 1, 1442-1443.
29. H. Kanazawa, S. Nishigaki, K. Singa, J. Heterocycl. Chem. 1984, 21, 969-974.
30. H. Xiao, G. Ouyang, X. Sun, X. Yao, et al., Hecheng Huaxue 2005, 13, 600-602.
31. A. Kimata, H. Fukuuchi, S. Ohta, T. Suzuki, N. Miyata, J. Med. Chem. 2007, 50, 5053-5056.
32. S. G. Franzblau, R. S. Witzig, J. C. McLaughlin, P. Torres, et al., J. Clin. Microbiol. 1998, 36, 362-366.
33. J. D. Vanitha, C. N. Paramasivan, Diagn. Microbiol. Infect. Dis. 2004, 49, 179-182.
34. R. S. Reis, I. Neves, S. L. S. Lourenco, L. S. Fonseca, M. C. S. Lourenço, J. Clin. Microbiol. 2004, 42, 2247-2248.